The Massachusetts Male Aging Study followed 1,532 men across three data collection rounds spanning 1987 to 2004. Researchers compared men of the same age at different calendar dates, separating the effects of getting older from broader population-level changes over time.

After adjusting for age, the average total testosterone fell by roughly 1.2% per year. This means a man born in 1970 would be expected to have meaningfully lower testosterone at any given age than a man born in 1940. The decline could not be explained by observed changes in smoking, alcohol use, body weight, or general health.

This was the first large study to document a generational decline in testosterone beyond what normal aging would predict, and it has been cited extensively in the medical literature since its publication.

Researchers used data from three Finnish population health surveys conducted in 1972, 1977, and 2002. By comparing men of the same age born in different decades, they could separate aging effects from generational shifts.

The decline was seen across multiple age groups, not just older men. Even after accounting for the increase in body mass index over time, the drop remained statistically significant. Luteinizing hormone, a brain signal that tells the testes to produce testosterone, did not rise as expected if the testes alone were failing - suggesting the decline may involve changes higher up in the hormonal control system.

Finland provides an especially useful population to study because healthcare records are comprehensive and the population is relatively homogeneous, reducing the chance that ethnic or socioeconomic mixing could explain the trend.

Researchers analyzed data from the National Health and Nutrition Examination Survey (NHANES), which draws a new nationally representative sample every two years. This study focused specifically on adolescent and young adult men, a group where declining testosterone is especially concerning.

Even after controlling for body mass index, physical activity, smoking, alcohol use, and chronic diseases, the downward trend remained significant. Among men with a normal BMI, average testosterone still fell from 665 to 529 ng/dL. This finding is important because it weakens the argument that rising obesity alone explains the population-level decline.

The decline was seen across racial and ethnic groups and was not explained by changes in the composition of the survey samples over time.

Researchers at Maccabi Healthcare Services, one of Israel''s largest health providers covering about 25% of the population, analyzed all testosterone tests ordered for male members aged 13-80 over a 13-year period. The sheer size of the dataset - over 100,000 men - made it one of the largest studies on this topic.

The decline was consistent across most age groups, suggesting it was not simply an artifact of older men being tested more often over time. The researchers noted that while obesity rates did increase during the study period, the testosterone decline was steeper than what obesity changes alone would predict.

Israel provides a useful setting because it has universal healthcare, reducing the chance that changes in who gets tested could skew the results.

Researchers followed military veterans across six measurement cycles over two decades, tracking both weight changes and testosterone levels in the same individuals over time. This longitudinal design is stronger than comparing different groups of men at different time points.

Among men whose weight stayed the same or decreased, testosterone still fell substantially. This directly challenges the argument that the secular decline is simply an artifact of the obesity epidemic. If weight gain were the primary driver, men who did not gain weight should have maintained stable testosterone levels - but they did not.

The military veteran population is useful because their baseline fitness levels were higher than the general population, making it harder to attribute the decline to poor lifestyle habits.

Researchers conducted the largest systematic review to date on secular trends in male reproductive hormones. They analyzed 1,504 study groups from papers published between 1971 and 2024, covering 1,064,891 subjects total.

The meta-regression showed a statistically significant negative relationship between the year a study was conducted and the testosterone levels it measured. Both testosterone and luteinizing hormone declined over time, independent of age and body mass. The simultaneous drop in luteinizing hormone is critical because it points to changes in the hypothalamic-pituitary axis (the brain''s hormonal control system) rather than testicular failure alone.

The authors proposed that environmental endocrine disruptors, metabolic changes, and lifestyle shifts may be resetting the entire hormonal control system at a population level.

Using the same cohort as the landmark 2007 decline paper, researchers specifically asked how much of the observed testosterone decline could be attributed to worsening health and lifestyle factors versus an unexplained generational shift. They modeled the contributions of developing diabetes, gaining weight, losing a spouse, and changes in smoking and alcohol use.

Health and lifestyle changes did explain a substantial portion of individual testosterone decline. However, a significant calendar-time effect remained after all these adjustments. Something beyond the measured health and behavior changes was driving testosterone levels down across the population.

This study is important because it directly addresses the most common counterargument - that people are just getting less healthy - and shows it cannot fully explain the trend.

Researchers analyzed serum samples from four independent Danish population surveys spanning nearly 20 years. The raw trends showed clearly lower testosterone and SHBG (a protein that carries testosterone in the blood) in men measured more recently, consistent with a secular decline.

The study is notable because Denmark maintains excellent population health registries and uses random sampling methods that minimize selection bias. The downward trends were consistent across age groups.

While the testosterone decline lost statistical significance after adjusting for BMI in this particular dataset, the SHBG decline remained significant even after adjustment. SHBG is produced by the liver and reflects broader metabolic and hormonal changes, adding another dimension to the evidence that something in the male hormonal environment is shifting over time.

Researchers measured phthalate metabolites in urine and testosterone in blood from participants in the 2011-2012 National Health and Nutrition Examination Survey. Phthalates are endocrine-disrupting chemicals found in flexible plastics, food containers, cosmetics, and many household products.

The strongest associations were seen in boys aged 6-12, where the most common phthalate metabolites (from a chemical called DEHP) were linked to 24-34% lower testosterone levels. Significant inverse associations were also found in adult men and women.

Phthalate exposure has increased dramatically over recent decades as plastic use has grown. If these chemicals genuinely suppress testosterone production, the rising environmental exposure could partly explain why each generation of men has lower testosterone than the previous one - independent of body weight changes.

The European Male Ageing Study followed community-dwelling men aged 40-79 from centers in Manchester, Leuven, Malmoe, Tartu, Lodz, Szeged, Florence, and Santiago de Compostela. Testosterone and other hormones were measured at baseline and again about 4.3 years later.

Free testosterone (the biologically active form not bound to carrier proteins) declined by about 3.83 pmol/L per year on average. Men who gained more than 15% of their body weight experienced an additional drop roughly equivalent to 10 years of aging. However, even men who maintained their weight showed some decline.

The multi-country design strengthens the finding because it shows the decline is not unique to a single country or healthcare system. The fact that weight gain magnifies the decline but does not fully explain it supports both sides of the debate to some degree.

This review synthesized decades of research on testosterone trends, covering epidemiological evidence, proposed biological mechanisms, and clinical consequences. The authors concluded that the weight of evidence supports a real generational decline that goes beyond what aging and obesity alone can explain.

The review highlighted environmental endocrine disruptors - chemicals like phthalates, bisphenol A, and certain pesticides that interfere with hormone production - as a plausible contributor. It also discussed how sedentary lifestyles, poor sleep, chronic stress, and metabolic syndrome may each contribute to lower testosterone through different biological pathways.

The clinical consequences discussed include reduced fertility, increased cardiovascular risk, loss of bone density, mood disturbances, and decreased muscle mass - suggesting the decline has real health implications beyond just a number on a lab report.